Crossmark

Identified γ-glutamyl cyclotransferase (GGCT) as a novel regulator in the progression and immunotherapy of pancreatic ductal adenocarcinoma through multi-omics analysis and experiments

Crossref DOI link: https://doi.org/10.1007/s00432-024-05789-0

Published Online: 2024-06-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zheng, Ying

Xiong, Qunli

Yang, Yang

Ma, Yifei

Zhu, Qing
Funding

Funding for this research was provided by:

Qing Zhu (ZYJC21042)

Qing Zhu (ZYJC21042)

Qing Zhu (ZYJC21042)

Qing Zhu (ZYJC21042)

Qing Zhu (ZYJC21042)
License Information

Text and Data Mining valid from 2024-06-25

Version of Record valid from 2024-06-25
More Information

Article History

Received: 20 March 2024

Accepted: 7 May 2024

First Online: 25 June 2024

Declarations

:

: The authors declare no competing interests.

: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Document is current

Any future updates will be listed below